These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 31426611)

  • 21. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-mediated cancer stem cell resistance and targeted therapy.
    Sun X; Lv X; Yan Y; Zhao Y; Ma R; He M; Wei M
    Biomed Pharmacother; 2020 Oct; 130():110623. PubMed ID: 32791395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
    Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
    Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches to target cancer stem cells: current scenario.
    Insan MB; Jaitak V
    Mini Rev Med Chem; 2014 Jan; 14(1):20-34. PubMed ID: 24195662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
    Das M; Law S
    Int J Biochem Cell Biol; 2018 Oct; 103():115-124. PubMed ID: 30153480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
    Lee SH; Reed-Newman T; Anant S; Ramasamy TS
    Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
    Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
    Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches to Targeting Cancer Stem Cells in Solid Tumors.
    Caldas-Lopes E; Gomez-Arteaga A; Guzman ML
    Curr Stem Cell Res Ther; 2019; 14(5):421-427. PubMed ID: 30806324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
    Ingavle G; Das M
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Stem Cells: Root of the Evil.
    Erkisa M; Karakas D; Ulukaya E
    Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Advances and Challenges of Targeting Cancer Stem Cells.
    Dashzeveg NK; Taftaf R; Ramos EK; Torre-Healy L; Chumakova A; Silver DJ; Alban TJ; Sinyuk M; Thiagarajan PS; Jarrar AM; Turaga SM; Saygin C; Mulkearns-Hubert E; Hitomi M; Rich JN; Gerson SL; Lathia JD; Liu H
    Cancer Res; 2017 Oct; 77(19):5222-5227. PubMed ID: 28928129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
    Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
    Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.